Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double‐blind, placebo‐controlled study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 3, 2015-03 ,pp. : 304-308

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: a double-blind, placebo-controlled, clinical trial

By Kaku Kohei  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1111-1119

Informa Healthcare

Access to resources Recommend Favorite

Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: A randomized, double-blind, placebo-controlled study

By Thusgaard Marianne   Christensen Jesper   Mørn Birgitte   Andersen Tina   Vige Runar   Arildsen Hanne   Schmidt Erik   Nielsen Henrik  

Scandinavian Journal of Infectious Diseases, Vol. 41, Iss. 10, 2009-01 ,pp. : 760-766

Informa Healthcare

Access to resources Recommend Favorite

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

By Lems W.   Lodder M.   Lips P.   Bijlsma J.   Geusens P.   Schrameijer N.   Ven C.   Dijkmans B.  

Osteoporosis International, Vol. 17, Iss. 5, 2006-05 ,pp. : 716-723

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study*

By Pratley Richard E.   Reusch Jane E.-B.   Fleck Penny R.   Wilson Craig A.   Mekki Qais  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2361-2371

Informa Healthcare

Access to resources Recommend Favorite